For Researchers - Search Now For Contributors - Join Now

News & Events

Press Releases

Widespread underuse of specimens concerns biobanks, says new research

LEXINGTON, MA., May 22, 2018 - A majority of global biobanks – collectors of human fluids, cells and tissue for biomedical research – are underutilizing their specimens while struggling with financial pressures that threaten their long-term viability, suggests a new review of biobanks and biorepositories conducted by iSpecimen.

Read more

Press Releases

iSpecimen® Advisory Board to Help Advance Company’s Mission of Streamlining Biospecimen Procurement for Research

LEXINGTON, MA, April 25, 2018 – iSpecimen today announced it has established a panel of respected partners and industry experts to counsel the company in its mission of supplying biomedical researchers with the specimens they need from the patients who have them.

Read more

Press Releases

Coming Soon to the Siemens Healthineers Aptio Automation System: iSpecimen Integrated Solution

Lexington, MA - April 12, 2018 - Siemens Healthineers and iSpecimen today announced they will aid laboratories in generating new sources of revenue through the integration of Siemens Healthineers’ laboratory automation systems with iSpecimen’s biospecimen marketplace. Participating labs can use the CentraLink Data Management System and Aptio® Automation to automate retrieval of samples requested by researchers via the iSpecimen Marketplace.

Read more

Press Releases

iSpecimen® Director of Marketing Jeff Goldman to Present Cutting-Edge Biobanking Strategy

ZURICH, Switzerland, March 13, 2018 – iSpecimen Director of Marketing Jeff Goldman and partner Science Exchange will co-present today, March 13, at the ProcureCon Europe Pharma Conference in Switzerland. The presentation will demonstrate how iSpecimen’s digital marketplace addresses challenges along the research supply chain, and share industry perspectives on biobanking and procurement.

Read more

Press Releases

iSpecimen® Founder and CEO Chris Ianelli to Co-Panel at Molecular Med TRICON

San Francisco, Calif., Feb. 12, 2018 – iSpecimen Founder and CEO Christopher Ianelli, MD, PhD, will co-present on the emerging technologies and industry perspectives in molecular medicine on Wednesday, Feb. 14 at Molecular Med TRICON in San Francisco.

Read more

In the News

A biospecimen marketplace to drive precision research

December 18, 2017 - Becker's Hospital Review - As the new quest for individualized cures progresses and patients increasingly constitute an “N of 1,” it’s becoming apparent that precision research will be essential to achieving the promise of precision medicine.

Read more

Press Releases

iSpecimen® Announces Data Connector Program to Seamlessly Connect Biospecimen Providers to the iSpecimen Marketplace

Lexington, MA, Dec. 5, 2017 – iSpecimen today announced the iSpecimen Data Connector Program, an initiative that enables health-care organizations to seamlessly connect their sample and data management systems to the iSpecimen Marketplace, making it easier than ever to offer their biospecimens to researchers.

Read more

Press Releases

Genohm and iSpecimen® Partner to Enable their Customers to Seamlessly Connect their Sample Inventories to the iSpecimen Marketplace

LAUSANNE, Switzerland, and LEXINGTON, MA, Dec. 5, 2017 – Genohm and iSpecimen today jointly announced that Genohm has established a partnership with iSpecimen to enable users of the SLIMS laboratory information management system to seamlessly connect to the iSpecimen Marketplace.

The combined solution will allow Genohm customers to easily make their inventories of biospecimens and associated data available to researchers around the world through the marketplace, and then accept, fulfill and track associated orders for samples. These new capabilities enable Genohm customers to increase revenue as well as the utilization rates of their banked specimens.

Read more

Press Releases

iSpecimen and Science Exchange Announce Technology Integration to Allow Instant Access to Human Biospecimens

Lexington, MA and Palo Alto, CA – Oct. 24, 2017 – iSpecimen and Science Exchange today announced a marketplace technology integration that will allow Science Exchange users to directly search for biospecimens available in the iSpecimen Marketplace via a single user interface.

Read more

Press Releases

iSpecimen Announces Online Marketplace Expansion

Lexington, MA – October 23, 2017 – iSpecimen® today announced the expansion of the iSpecimen Marketplace – an online specimen matching platform launched in June of this year that instantly connects life science researchers who need human biospecimens with the healthcare organizations that have them. Hundreds of biotech, pharmaceutical, and academic institutions have signed on as marketplace users, collectively conducting thousands of searches across millions of patients and samples available for research. Initially launched providing access to one million banked samples, the iSpecimen Marketplace now also provides access to 25 million clinical remnants annually.

Read more

In the News

Add to cart: Online marketplaces join forces to provide researchers instant access to biospecimens

October 2, 2017 - Outsourcing Pharma - To simplify the human biospecimens procurement process, the online marketplace for outsourced scientific services, Scientist.com, has teamed up with iSpecimen.

Read more

Press Releases

Scientist.com and iSpecimen Simplify Research Access to Human Biospecimens

San Diego, CA and Lexington, MA – October 2, 2017 – Scientist.com, the life science industry’s leading online marketplace for outsourced scientific services, and iSpecimen, a leading supplier of human biospecimens used for scientific research, today announced that they will simplify access to highly annotated human samples of all types. Researchers in the pharmaceutical and biotechnology industries can now access millions of data-rich human biospecimens and acquire them online under a single pre-established legal agreement.

Read more

In the News

At iSpecimen, Biosamples Get Shipped Fast When Researchers Need Them

August 21, 2017 - The Boston Globe - More than 50 hospital systems and commercial laboratory networks in Massachusetts and elsewhere have signed deals with iSpecimen, giving researchers access to millions of tissue and fluid specimens. That could greatly expand the power of labs like SQZ to conduct cutting-edge research.

Read more

In the News

iSpecimen Launches First Online Marketplace for Human Biospecimens

June 15, 2017 - HIT Consultant - iSpecimen, a Lexington, MA-based startup has launched the iSpecimen Marketplace, an online, data-rich platform that connects life science researchers who need human biospecimens to the healthcare organizations that have them. Using a powerful, multi-faceted search platform, the marketplace enables medical researchers to intuitively search millions of available human biospecimens and solves one of the research industry’s biggest challenges – how to compliantly obtain quality biospecimens in a cost-effective manner. Through the marketplace, researchers gain instant access to iSpecimen’s growing, federated network of healthcare providers and biobanks, giving network participants (specimen providers) the opportunity to more broadly contribute to medical research as well as their bottom line.

Read more

In the News

iSpecimen Launches Online Platform for Connecting Researchers with Samples in Real Time

June 14, 2017 - ClinicalOMICS - Human biospecimen marketplace iSpecimen, has launched an online platform called iSpecimen Marketplace with the intent of quickly connecting life sciences researchers in need of specific biosamples with the biobanks and clinical laboratories that have them. The searchable platform, which carries broad similarities to other consumer marketplaces like travel-oriented sites Travelocity and Kayak, provides a search platform for researchers to enter the type of sample they seek, then narrow it down to their specific parameters in order to identify the most relevant biospecimens available from the suppliers in the network.

Read more

In the News

iSpecimen Launches Biospecimen Marketplace

June 13, 2017 - BIO IT World - iSpecimen launched its marketplace today, an online shopping platform to connect life science researchers to healthcare organizations with human biospecimens. The platform is designed to maximize user experience. Researchers start by requesting tissue, biological fluids, or viable cells. From there, the platform pulls up a results list that is very similar to results in Amazon or Kayak. On the left, a panel of check boxes and sliders help researchers narrow their results by specimen details, molecular characterization, patient demographics, histology, and more.

Read more

In the News

Massachusetts Biotech iSpecimen Launches Amazon (AMZN)-Like Marketplace for Scientists

June 13, 2017 - BioSpace - In 2009, Lexington, Mass.-based iSpecimen launched with a database of biological samples that can be used by researchers. Today the company announced its iSpecimen Marketplace, where researchers can find the specimen they’re interested in and buy it at the same time. “What Amazon (AMZN) did for bookstores, we’re going to be doing for bio-repositories,” Christopher Ianelli, the company’s founder and chief executive officer, told the Boston Business Journal.

Read more

In the News

Lexington Firm Launches Amazon-Like Marketplace for Life Science Research

June 13, 2017 - Boston Business Journal - A Lexington company has launched a new online marketplace that connects medical researchers with suppliers of human tissue and other biospecimens — a kind of Amazon.com for the life sciences industry. The privately-held company, iSpecimen, unveiled the marketplace on Tuesday. The platform aims to solve a problem that remains all too common among scientists: canvassing hospitals, labs and other healthcare organizations to find specific, high-quality samples of human material needed to conduct research. Such searches can be time-consuming and, if they fail to identify adequate biospecimens, force researchers to change or curtail the scope of their projects.

Read more

Press Releases

iSpecimen Unveils Online Marketplace for Human Biospecimens

Lexington, MA – June 13, 2017 – iSpecimen® today launched the iSpecimen Marketplace – an online, data-rich platform that connects life science researchers who need human biospecimens to the healthcare organizations that have them. Using a powerful, multi-faceted search platform, the marketplace enables medical researchers to intuitively search millions of available human biospecimens and solves one of the research industry’s biggest challenges – how to compliantly obtain quality biospecimens in a cost-effective manner. Through the marketplace, researchers gain instant access to iSpecimen’s growing, federated network of healthcare providers and biobanks, giving network participants (specimen providers) the opportunity to more broadly contribute to medical research as well as their bottom line.

Read more

In the News

iSpecimen Building Cloud-Based System for Patient Sample Procurement

March 17, 2017 - 360Dx - Sample collection firm iSpecimen is developing a cloud-based system for streamlining procurement of patient samples. The system, which the company plans to launch in May, will allow researchers to place online requests for specific sample types that iSpecimen will then work to fill via its various clinical partners. Comparing it to travel websites like Kayak.com, Christopher Ianelli, iSpecimen's founder and CEO, said the tool will allow users to "go to our website and enter in exactly what they need, and then we'll search across our network and tell them when we find what they are looking for." According to the company, its network of sample providers currently consists of more than 250 hospitals labs, 1,000 clinics and medical practices, 12 biorepositories, 10 commercial labs, six clinical trial organizations, and one large blood center.

Read more

Press Releases

Doctors Pathology Service (DPS) Joins Growing Biospecimens for Research Program Offered by iSpecimen and the Delaware Health Information Network (DHIN)

Lexington, MA – March 22, 2017 – iSpecimen®, the marketplace for human biospecimen collections, today announced that Doctors Pathology Service (DPS), a full-service anatomic pathology reference lab serving the mid-Atlantic region of the United States, has joined a program offered by iSpecimen and the Delaware Health Information Network (DHIN) to make human biospecimens and associated data available to medical researchers.

Read more

In the News

iSpecimen Creates Marketplace for Clinical Discards

February 27, 2017 - Diagnostic Testing & Emerging Technologies - iSpecimen (Lexington, Mass.) can be thought of as a cross between a dating site and an online marketplace for human biospecimens. The company has built a turnkey solution that connects providers, such as hospital systems, commercial labs, and biobanks, to researchers looking to gain access to these specimens and associated data from electronic medical records and other sources. It’s a win-win situation, with providers having a new market for both soon-to-be discarded and banked specimens, researchers more efficiently accessing needed specimens and rich clinical data, and patients getting a chance to make a contribution to research.

Read more

In the News

Raw Materials: iSpecimen Marketplace Platform Makes It Easy To Find Biospecimens

February 24, 2017 - BIO-IT World - We are, in many ways, spoiled for choice. In nearly everything we buy we expect to be able to shop consolidated market places, with the wealth of our options organized before us. We want to be able to search and filter our own results. And we really like one-click shopping. The same is true for human samples.

Read more

Press Releases

iSpecimen Founder & CEO to Present on Emerging Technology Keynote Panel at Molecular Med Tri-Con

Lexington, MA – February 16, 2017 – iSpecimen®, the marketplace for human biospecimen collections, today announced that its founder and chief executive officer, Christopher Ianelli, MD, PhD, will join a panel of medical innovators next week in presenting emerging technologies for molecular medicine. This keynote panel will take place on Wednesday, February 22 as part of the Cambridge HealthTech Institute’s Molecular Med Tri-Con event in San Francisco.

Read more

In the News

Global Outlook for Biotech IPOs Looks Bright; Will “Precision” and “Convergence” be the New Mantras?

January 22, 2017 - Monday Morning - Up first is Dr. Christopher Ianelli, founder and CEO of iSpecimen. His company is a supplier of human biospecimens to the life science industry, including pharmaceutical, diagnostic, and academic researchers. “In 2016, ‘precision medicine’ reigned supreme as the catch phrase of the year,” he writes, according to STAT. Dr. Ianelli then goes on to predict, “‘Precision research,’ or the ever-more targeted research necessary to make good on the promise of precision medicine, will propel forward in 2017. Refined research questions requiring the interrogation of highly specific biospecimens and associated data sets will form the backbone of this precision research wave.”

Read more

In the News

From the Mailbag: Reader Predictions for the Coming Year in Biopharma

January 3, 2017 - STAT News - Sharper focus on precision research: "Precision research, or the ever-more targeted research necessary to make good on the promise of precision medicine, will propel forward in 2017. With nationwide health care initiatives getting attention, like the National Institutes of Health’s PMI and Joe Biden’s cancer moonshot, scientists are in pursuit of customized therapies for an N of 1. Refined research questions requiring the interrogation of highly specific biospecimens and associated data sets will form the backbone of this precision research wave." — Dr. Christopher Ianelli, founder and CEO of iSpecimen

Read more

In the News

iSpecimen® Announces Expansion

December 9, 2016 - Medical Horizons - iSpecimen®, a source of customized human biospecimen collections, recently announced that it has made sizeable increases to the number and types of clinical organizations participating in its partner network. As a result, the company can now offer scientists faster access to a more diverse array of human biospecimens for medical research.

Read more

In the News

iSpecimen Announces Marketplace Expansion

December 8, 2016 - Lab Manager - iSpecimen, a trusted source of customized human biospecimen collections, today announced that it has made sizeable increases to the number and types of clinical organizations participating in its partner network. As a result, the company can now offer scientists faster access to a more diverse array of human biospecimens for medical research. Initially founded as a provider of remnant clinical biospecimens, iSpecimen can additionally source biospecimens collected specifically for research from its partner network that includes hospitals, commercial labs, clinics and practice groups, biorepositories, blood centers, health information exchanges, and clinical research sites.

Read more

In the News

Michigan Roundup – Great Lakes Health Connect

December 6, 2016 - Xconomy - Great Lakes Health Connect (GLHC), Michigan’s leading health information exchange (HIE), has announced a partnership with Massachusetts-based iSpecimen to help advance precision medicine research. All GLHC participating providers (129 hospitals and over 4,000 other members) will now have the option to donate their patient-consented biospecimens to scientists doing diagnostic and clinical testing.

Read more

Press Releases

iSpecimen Announces Marketplace Expansion

Lexington, MA – December 7, 2016 – iSpecimen®, a trusted source of customized human biospecimen collections, today announced that it has made sizeable increases to the number and types of clinical organizations participating in its partner network. As a result, the company can now offer scientists faster access to a more diverse array of human biospecimens for medical research. Initially founded as a provider of remnant clinical biospecimens, iSpecimen can additionally source biospecimens collected specifically for research from its partner network that includes hospitals, commercial labs, clinics and practice groups, biorepositories, blood centers, health information exchanges, and clinical research sites.

Read more

In the News

Health Information Exchange Partners with Specimen Supplier

November 24, 2016 - Grand Rapids Business Journal - A local health information exchange will provide human bio-specimens and data to a supplier serving the medical research industry under a new partnership. Grand Rapids-based Great Lakes Health Connect, or GLHC, a nonprofit, has agreed to partner with Lexington, Massachusetts-based iSpecimen, a privately held company.

Read more

In the News

In Brief This Week: Agilent, Mogene, iSpecimen, and More

November 18, 2016 - GenomeWeb - Customized human biospecimen collections developer iSpecimen said this week that it has signed an agreement to help New Mexico-based commercial lab TriCore Reference Laboratories make patient biospecimens and associated data available for research. iSpecimen will use its cloud-based technology to analyze data generated by TriCore to match researchers with annotated, de-identified samples for their studies.

Read more

In the News

iSpecimen and TriCore Reference Laboratories Announce Collaboration to Make Human Biospecimens and Data Available for Research

November 16, 2016 - Lab Manager - iSpecimen®, a trusted source of customized human biospecimen collections, and TriCore Reference Laboratories (TriCore), New Mexico's largest commercial reference lab, today (Nov. 14) announced an agreement through which iSpecimen will serve as a TriCore channel partner for making patient biospecimens and associated data available for research. iSpecimen's cloud-based technology will be used to tap into the flow of patients, specimens, and data running through the TriCore organization, matching researchers with a variety of annotated, de-identified samples to fuel their studies.

Read more

In the News

TriCore Lab Signs Deal with iSpecimen

November 14, 2016 - Albuquerque Journal - New Mexico-based TriCore Reference Laboratories on Monday said it has inked an agreement with iSpecimen, a Boston company that connects medical researchers with appropriate specimens from laboratories and hospitals. “TriCore has been a long-time supporter of the advancement of biomedical research,” said Eric Carbonneau, director of the core lab operations & research institute at TriCore. “The new agreement with iSpecimen will allow us to expand our reach across the scientific community."

Read more

In the News

Weekly Roundup of HIT Contracts & Implementations – iSpecimen and Great Lakes Health Connect

November 11, 2016 - Health Data Management - Patients benefiting from the Great Lakes Health Connect health information exchange in Michigan now will be able consent to donate biospecimens to researchers. The HIE has contracted with vendor iSpecimen, enabling researchers to use their electronic health record system to view and select specific samples in real-time, as well as get patients’ medical histories upon consent. Great Lakes Health Connect participants manage more than 90 percent of hospital beds in the state and have more than 7 million individual patient records.

Read more

In the News

iSpecimen, Great Lakes Health Connect to Form Biospecimen HIE

November 9, 2016 - Clinical Innovation & Technology - iSpecimen, a supplier of human biospecimens, and Great Lakes Health Connect (GLHC), the leading health information exchange (HIE) in Michigan, have teamed to improve the data network of biospecimens available for research purposes. With 129 hospitals and 4,000 primary, specialty and allied care organizations, GLHC is in charge of over 90 percent of hospital beds in Michigan with more than seven million patient records. By consolidating the data on human biospecimens, iSpecimen is able to sort large amounts of data form electronic medical records and make them easily accessible to researchers looking for a specific set of patients.

Read more

Press Releases

iSpecimen and TriCore Reference Laboratories Announce Collaboration to Make Human Biospecimens and Data Available for Research

Lexington, Mass. & Albuquerque, N.M., November 14, 2016 – iSpecimen®, a trusted source of customized human biospecimen collections, and TriCore Reference Laboratories (TriCore), New Mexico’s largest commercial reference lab, today announced an agreement through which iSpecimen will serve as a TriCore channel partner for making patient biospecimens and associated data available for research. iSpecimen’s cloud-based technology will be used to tap into the flow of patients, specimens, and data running through the TriCore organization, matching researchers with a variety of annotated, de-identified samples to fuel their studies.

Read more

In the News

Medical Philanthropy Crucial to Advance Precision Medicine

November 7, 2016 - MedCity News - In mid-October, the National Institutes of Health announced that its Precision Medicine Initiative (PMI) Cohort Program has expanded to include four additional regional medical center groups – the California Precision Medicine Consortium, Geisinger Health System, the New England Precision Medicine Consortium, and the Trans-American Consortium for the Health Care Systems Research Network. These groups, which collectively consist of nearly 20 distinct institutions, will work in concert with the other existing healthcare provider organizations (HPOs) taking part in the PMI to recruit the one million participants necessary to complete the PMI cohort. More than ever, medical philanthropy – the willingness of patients to give of themselves for the advancement of healthcare research – will be critical to achieving this as well as other precision medicine endeavors.

Read more

In the News

State HIE News and Updates

November 4, 2016 - HIE Answers - iSpecimen, a source of customized human biospecimen collections, announced an agreement with GLHC. This agreement will drive medical innovation by making human biospecimens and associated data from within the GLHC network available to research programs. With 129 hospital participants as well as 4,000 primary, specialty, and allied care organization members, GLHC participants manage more than 90% of the hospital beds in the state and over seven million individual patient records.

Read more

In the News

iSpecimen, Great Lakes Health Partner for Medical Research

November 4, 2016 - Medical Device Business Review - iSpecimen has signed an agreement with Great Lakes Health Connect (GLHC), Michigan's leading health information exchange (HIE). This agreement will drive medical innovation by making human biospecimens and associated data from within the GLHC network available to research programs. With 129 hospital participants as well as 4,000 primary, specialty, and allied care organization members, GLHC participants manage more than 90% of the hospital beds in the state and over seven million individual patient records.

Read more

In the News

iSpecimen and Great Lakes Health Connect Announce Collaboration to Drive Medical Research

November 4, 2016 - Lab Manager - iSpecimen, a trusted source of customized human biospecimen collections, today (Nov. 3) announced an agreement with Great Lakes Health Connect (GLHC), Michigan’s leading health information exchange (HIE). This agreement will drive medical innovation by making human biospecimens and associated data from within the GLHC network available to research programs. With 129 hospital participants as well as 4,000 primary, specialty, and allied care organization members, GLHC participants manage more than 90 percent of the hospital beds in the state and over seven million individual patient records.

Read more

Press Releases

iSpecimen and Great Lakes Health Connect Announce Collaboration to Drive Medical Research

Lexington, MA – November 3, 2016 – iSpecimen®, a trusted source of customized human biospecimen collections, today announced an agreement with Great Lakes Health Connect (GLHC), Michigan’s leading health information exchange (HIE). This agreement will drive medical innovation by making human biospecimens and associated data from within the GLHC network available to research programs. With 129 hospital participants as well as 4,000 primary, specialty, and allied care organization members, GLHC participants manage more than 90% of the hospital beds in the state and over seven million individual patient records.

Read more

In the News

One Fine Specimen: Where Biopharma Competitiveness Really Begins

October 21, 2016 - PharmaLive - Competition amongst biotech and pharmaceutical companies is certainly nothing new, with firms working arduously to maintain solid pipelines, win disease state areas, and attract and retain top talent. An industry marked by mass consolidation of established organizations on one end, and seemingly ongoing entry of “next-generation” start-ups on the other, it is no surprise that differentiation and market share are top-of-mind for biopharma executives. Yet, far before there are new therapies to set a firm apart, or enough sales to garner Wall Street’s attention, there is a far more fundamental need that competitiveness will ultimately hinge on – and that is the need for high-quality, diversified, annotated human biospecimens. Without access to a ready supply of these specimens, particularly as precision medicine continues to reign supreme, today’s biopharma companies will falter, quite literally, getting off the bench.

Read more

In the News

Mayo Clinic’s Collaboration with iSpecimen® May Bolster Research

September 12, 2016 - Mayo Clinic Individualized Medicine Blog - iSpecimen®, a privately held biomedical company, has announced a new collaboration with Mayo Clinic Center for Individualized Medicine to make serum from cancer patients more readily available to scientists. Bringing together patient samples, scientists and biomedical business is an important step toward advancing research into personalized treatments for cancer, Alzheimer’s and many other diseases. “Breakthrough discoveries would not be possible without the human samples investigators use in their studies,” says Stephen Thibodeau, Ph.D., the David F. and Margaret T. Grohne Director, Biorepositories Program, Mayo Clinic Center for Individualized Medicine.”

Read more

In the News

Mayo Clinic, iSpecimen Collaborate on Cancer/Normal Serum Biobank

September 12, 2016 - HIT Consultant - Mayo Clinic Center for Individualized Medicine has selected iSpecimen to serve as the exclusive channel partner for the Mayo Clinic Cancer/Normal Serum Biobank, connecting biomedical researchers with the samples and associated data for their studies. The Cancer/Normal Serum Biobank has approximately 130,000 frozen vials of serum from about 17,000 unique, consented patients. iSpecimen will manage the serum inventory and associated data through its cloud-based technology solution, matching researchers to the right samples to fuel their studies.

Read more

In the News

Donating Biospecimens: Most Americans Say Yes

September 12, 2016 - Bioscience Technology - Bioscience Technology chatted with Chris Ianelli, CEO of iSpecimen, to discuss the public attitude toward donating biological samples for clinical research, why participation in research efforts is important, and some roadblocks to sample collection.

Read more

In the News

Mayo Clinic Inks Biosample Management Deal With iSpecimen

September 12, 2016 - GenomeWeb - Biological specimen provider iSpecimen announced today that it has signed an agreement to exclusively manage serum samples and associated data for the Mayo Clinic Center for Individualized Medicine's Cancer Serum Biobank. The biobank holds roughly 130,000 frozen serum samples collected between 1975 and 1990 from about 17,000 unique Mayo Clinic patients covering 85 malignant and benign cancers, as well as normal controls. It also includes patient diagnosis and treatment data.

Read more

In the News

Mayo Clinic selects iSpecimen to facilitate biobank data, trials

September 12, 2016 - Becker's Health IT & CIO Review - Mayo Clinic Center for Individualized Medicine in Rochester, Minn., has selected iSpecimen to connect biomedical researchers with the samples and data held in the center's biobank for studies. The Cancer/Normal Serum Biobank holds approximately 130,000 frozen vials of serum from 17,000 consenting patients. The samples were collected between 1975 and 1990.

Read more

In the News

Mayo Clinic Connects with Biospecimen Collection Company for Personalized Medicine

September 12 - Healthcare Informatics - The Mayo Clinic’s Center for Individualized Medicine and the Lexington, Mass.-based biospecimen collection company iSpecimen are collaborating for a partnership that will connect biomedical researchers with samples from Mayo’s cancer serum biobank and associated data for their studies. The Cancer/Normal Serum Biobank, located on Mayo Clinic’s campus in Rochester, Minn., includes approximately 130,000 frozen vials of serum from about 17,000 unique, consented patients. The samples were collected between 1975 and 1990 across 85 different malignant and benign conditions. iSpecimen, which works to procure annotated samples for life science researchers, will manage the serum inventory and associated data through its cloud-based technology solution, matching researchers to the right samples to fuel their studies

Read more

In the News

Improving Clinical Specimen Management

September 8, 2016 - Lab Manager - Christopher Ianelli, chief executive officer of iSpecimen (Lexington, MA), points out a well-known problem that starts in preclinical research and goes through to clinical trials: a dearth of high-quality, data-rich human biospecimens. He adds, “Particularly with the surge of personalized medicine research, qualified human samples— with very specific specimen- and patient-level criteria— are in tremendous demand.”

Read more

Press Releases

iSpecimen Announces Collaboration with Mayo Clinic Center for Individualized Medicine

Lexington, MA – September 12, 2016 – iSpecimen®, a trusted source of customized human biospecimen collections, today announced that it has entered into an agreement with the Mayo Clinic Center for Individualized Medicine. Under the agreement, iSpecimen will serve as the exclusive channel partner for the Mayo Clinic Cancer/Normal Serum Biobank, connecting biomedical researchers with the samples and associated data for their studies. The Cancer/Normal Serum Biobank, located on Mayo Clinic’s campus in Rochester, Minnesota, includes approximately 130,000 frozen vials of serum from about 17,000 unique, consented patients. The samples were collected between 1975 and 1990 across 85 different malignant and benign conditions.

Read more

In the News

Maximizing EMR Investments Past the Point of Care

September 5, 2016 - ADVANCE for Health System Management - More than six years have passed since the Affordable Care Act (ACA) was signed into law and more than seven years since the Health Information Technology for Economic and Clinical Health (HITECH) Act took place. Tremendous strides have been made in the adoption of electronic medical records (EMR), which both laws sought to encourage, but there is still a long way to go for many medical care sites in terms of getting the most out of these heavy investments. One way to leverage EMR implementation, and reap both clinical and financial benefits over and above the intended benefits from better coordination of care, involves using the EMR past the point of care, to help researchers obtain biospecimens and data from patients they want to study. EMRs provide data aggregation that is wildly useful to researchers when it is de-identified and coupled with corresponding patient biospecimens. Let’s take a closer look at how this works.

Read more

In the News

The Philanthropic Patient – Another Reason Why Lab Testing Matters

August 23, 2016 - Lab Testing Matters - With ongoing media and public interest surrounding large-scale medical studies, such as the National Institute for Health’s Precision Medicine Initiative, people are increasingly more aware of the push for more personalized medicine and the need to tailor treatments to individuals. However, many patients remain unaware that biospecimen donation, whether of remnant samples or those collected expressly for research, is a simple and effective way to directly get involved and contribute. Educating patients that their specimens can be repurposed or collected proactively for research is an important step in sourcing more biospecimens to study – and also gratifying patients who want to help. As our research indicates, informed patients are eager to donate both remnant specimens as well as extra tubes of blood for a good cause.

Read more

In the News

Delaware HIE Teaming Up With iSpecimen to Turn Remnant Clinical Pathology Laboratory Specimens into Cash

August 3, 2016 - Dark Daily - Are health information networks alive and well in the United States? This sector of healthcare has been quiet in recent years. However, there is one statewide health information exchange (HIE) that is doing innovative things with clinical laboratory specimens. The Delaware Health Information Network (DHIN) has entered into a novel collaboration with iSpecimen that may help address the medical research community’s growing need for clinical specimens. At the same time, this agreement will also provide a much-needed new revenue stream for participating medical laboratories and hospitals.

Read more

In the News

Biospecimen Parameters Keep Pace with Precision Medicine

July 25, 2016 - Genetic Engineering News - As advances in precision medicine persist, and we collectively get closer to truly treating every patient as an “N of 1”, the challenge of finding the right human biospecimens on which to conduct preclinical research has grown significantly. Research into newer diagnostic tests, spanning an ever-growing range of “omics”, and treatment methods such as the recently approved cancer immunotherapies, require highly specific and highly characterized samples on which to conduct the research. These required characterizations may include specimen parameters that previously were unavailable—such as documented warm/cold ischemic times and specific molecular characterizations—in addition to precise patient parameters—such as specific treatment histories and responses. Finding these specimens has been difficult, at best, but with the advent of electronic medical records, big data technologies, more sophisticated specimen collection processes, increased genomic testing, and of course the overall progression of medicine, researchers have a myriad of new options to help them obtain the specimens they need from the patients they want.

Read more

In the News

Technology Drives Precision Health by Linking Hospitals and Researchers

June 26, 2016 - SearchHealth IT - Precision health will be achieved only if people and companies from various sectors work together. That's why President Barack Obama started his precision medicine initiative, in an effort to bring researchers, doctors and patients together and to encourage hospitals and people to share data in order to better understand certain diseases and discover cures. A small company in Massachusetts is working to achieve precision health by using their technology to bring hospitals and researchers together. Researchers have a growing need for patient samples and specimens -- including everything from blood, serum, plasma and tissue -- and providers such as hospital systems, practice groups, commercial labs and blood centers often take and collect specimens from patients. iSpecimen saw an opportunity here.

Read more

Press Releases

iSpecimen Appoints Eric Langlois as Vice President of Sales and Business Development

Lexington, MA - June 2, 2016 - iSpecimen®, a trusted source of customized human biospecimen collections, today announced the appointment of Eric Langlois to the position of Vice President of Sales and Business Development. In this role, Eric will be responsible for driving company sales as the firm offers a broader range of biospecimens to the scientific community, including biofluids, solid tissue, and viable cells, all paired with de-identified patient- and specimen-level data to meet researcher needs.

Read more

In the News

The Evolution of the Biobank

May 23, 2016 - ADVANCE for Laboratory - We recently spoke with Michael Clare-Salzler, MD, chair of the department of pathology, immunology and laboratory medicine at the University of Florida Health, as well as Amer Abouhamze, MHA, assistant director at the University of Florida Clinical & Translational Science Institute Biorepository, about the evolution of their state-of-the-art biobank. We discussed how data needs and improvements have changed the way the bank operates and what they deem critical for sustainability in meeting researchers' needs in the age of personalized medicine. iSpecimen is one of several distribution channels they use to move their specimens into biomedical research.

Read more

In the News

Leveraging Labs for Human Biospecimens

April 11, 2016 - Advance for Laboratory - Increasingly, hospital-based and commercial labs are being leveraged as a source of patient biospecimens and associated data for research. But how do patients feel about this? A new study commissioned by iSpecimen, but conducted independently, indicates that Americans are largely supportive of the use of their leftover clinical specimens for research, particularly when they learn that these specimens will otherwise be discarded and that their privacy can be ensured. Based on the study, it appears that Americans view this as a way they can contribute philanthropically to the advancement of medicine.

Read more

In the News

For the Delaware State HIE, Turning Clinical Specimens from Discards into Medical Research

March 29, 2016 - Healthcare Informatics - Through this program, healthcare information from participating DHIN members is de-identified and matched to corresponding remnant specimens at their provider sites. The specimens and their data are then searchable in real-time using iSpecimen's technology. When matches are made, iSpecimen's technology instructs laboratory personnel at participating provider sites to pick and ship the specimens to iSpecimen's research customers instead of discarding them as they usually do once clinical testing is complete.

Read more

In the News

PM360 Announces 2015 Innovators

December 16, 2015 - PM360 - iSpecimen has created a new paradigm for specimen procurement through which technology easily interfaces with health information systems at hospitals and labs to watch the flow of soon-to-be-discarded specimens and their associated data. When a match to a researcher request is made, specimens are picked, packed and shipped in an automated, HIPAA-compliant, efficient manner to researcher customers.

Read more

In the News

83% of patients willing to donate leftover blood samples to research

December 16, 2015 - MedCity News - Patients are getting more engaged in their care processes, which has led to an interesting new trend: We’re now seeing a more philanthropic patient. But not just in terms of donating dollars: Patients are willing to participate more and more in research, as Boston startup iSpecimen has found in an interesting independent analysis of patients participate in medical research. “The driving force behind this is for us to figure out, do patients really want to give something of themselves for healthcare research?” iSpecimen CEO Christopher Ianelli said in a phone interview.

Read more

Press Releases

The Philanthropic Patient: iSpecimen Study Shows that Americans Want to Help Advance Medical Research

Lexington, MA - December 16, 2015 - A new study commissioned by iSpecimen, a trusted source of customized human biospecimen collections, reveals that Americans want to support medical research and are willing to literally give of themselves. The study found 83% of Americans are willing to allow the use of their remnant clinical specimens in research, meaning once medical testing is completed, any leftover sample could be de-identified and made available to scientists who might need them in the search for new diagnostics or treatments. Close to two-thirds of the study sample were even willing to give an extra tube of blood if asked, for the sole purpose of use in research.

Read more

In the News

Challenges and Opportunities in Precision Medicine Outlined at the 7th Annual Personalized and Precision Medicine Conference

November 10, 2015 - Personalized Medicine Partnerships - Christopher Ianelli, MD, Ph.D., CEO of iSpecimen, took us full circle from participation back to protection again with an overview of a highly innovative new venture dedicated entirely to the reuse of remnant clinical specimens. Prompted by the recognition that a veritable goldmine of research was being actively wasted, iSpecimen was created as the steward to get discarded tissue and other samples into the R&D pipeline by matching with those who need them in a diversified data-flow network, while simultaneously promoting a more progressive consent process.

Read more

In the News

iSpecimen and the DHIN Announce Novel Program to Support Medical Research

November 10, 2015 - Advance for Laboratory - iSpecimen, a trusted source of customized human biospecimen collections, and the Delaware Health Information Network (DHIN), the nation's first operational statewide health information exchange (HIE), recently announced a novel collaboration to support medical research. The joint program allows hospitals and labs in the DHIN network to easily repurpose remnant clinical specimens - samples that would otherwise be discarded once patient testing is complete - into medical research programs, while reducing their costs to participate in DHIN. The organizations also announced Union Hospital as the first DHIN member to participate in the joint program.

Read more

In the News

Collaborative Program To Support Medical Research Announced

November 5, 2015 - Health IT Outcomes - In a novel collaborative program designed to support medical research, iSpecimen and the Delaware Health Information Network (DHIN), the nation’s first operational statewide health information exchange (HIE), have announced a joint program allowing hospitals and labs in the DHIN network to easily repurpose remnant clinical specimens into medical research programs while reducing their costs to participate in DHIN. Union Hospital will be the program’s initial member.

Read more

In the News

A New Role for HIEs: Exchanging Specimens

October 29, 2015 - Health Data Management - The Delaware Health Information Network, a statewide health information exchange that also serves parts of Maryland, is offering a novel new program—the exchange of medical specimens among hospitals and researchers. The idea is to repurpose liquid and solid clinical laboratory specimens, such as tissues, plasma, serum, blood and urine, so that hospitals no longer destroy leftover specimens but make them available—with patient consent—to medical research programs.

Read more

In the News

Delaware Health Info Network to Use Clinical Specimens for Medical Research

October 22, 2015 - Healthcare Informatics - The Delaware Health Information Network (DHIN) has announced a collaboration with the Lexington, Mass.-based biospecimen collection company iSpecimen that will allow hospitals and labs in the DHIN network to repurpose remnant clinical specimens into medical research programs. The specimens involved are samples that would otherwise be discarded once patient testing is complete, officials said in a joint announcement on the partnership. The organizations also announced Maryland-based Union Hospital as the first DHIN member to participate in the joint program.

Read more

In the News

Delaware Health Exchange Strikes Research Pact

October 22, 2015 - The News Journal - The Delaware Health Information Network, the state's healthcare data exchange network, has partnered with iSpecimen to support medical research.Under the agreement, hospitals and labs in the DHIN network will reuse patients' clinical specimens in medical research organizations. Lexington, Massachusetts-based iSpecimen, which collects medical samples and specimens, will be responsible for shipping and handling the specimens. All specimens and their data are searchable in real-time using iSpecimen's technology.

Read more

Press Releases

iSpecimen and the Delaware Health Information Network (DHIN) Announce Novel Program to Support Medical Research

Lexington, MA and Dover, DE – October 21, 2015 – iSpecimen, a trusted source of customized human biospecimen collections, and the Delaware Health Information Network (DHIN), the nation’s first operational statewide health information exchange (HIE), today announced a novel collaboration to support medical research. The joint program allows hospitals and labs in the DHIN network to easily repurpose remnant clinical specimens – samples that would otherwise be discarded once patient testing is complete – into medical research programs, while reducing their costs to participate in DHIN.

Read more

In the News

Proposed Changes to the Common Rule: Protection to Participation in Action

September 28, 2015 - Personalized Medicine Partnerships - On September 2, the government announced a proposal to update the Federal Policy for the Protection of Human Subjects, also known as the "Common Rule". According to the Department of Health & Human Services (HHS) the proposed changes are intended to strengthen human subjects’ protection while facilitating important research. The proposed changes are a real-time example of the shift that has been occurring in healthcare privacy: the shift from patient protection to protection and participation.

Read more

In the News

How a Cloud-Based Human Biospecimen Marketplace Works

September 10, 2015 - Lab Manager - With the promise of personalized medicine, the drug and diagnostic industries are booming, as are academic medical research programs. Never before have we seen such a proliferation of research questions, magnifying the need for human biospecimens on which to conduct the research. But finding qualified human biospecimens has long been a problem, with researchers often unable to find enough, or the right type, or the right quality to meet their needs.

Read more

In the News

iSpecimen: A next-gen biobank that’s based on the cloud

August 21, 2015 - MedCity News - Boston startup iSpecimen is building a sort of next-gen version of biobanking: It sources these remaining patient samples, and makes them – and the associated data – available to researchers on demand. The company doesn’t work like a typical biobank. It isn’t a repository for excreta. Rather, it’s more of a tech company that sources biological samples remotely from a hospital system or a clinical lab, then arranges for it to be sent to the researcher. And because iSpecimen doesn’t have to store its own samples, it can tout access to more than 10 million patient samples.

Read more

In the News

Data, Distribution, and Dynamic Collection

July 13, 2015 - Genetic Engineering News - In January of this year, President Obama announced he would allot $215 million for precision medicine research into the 2016 budget. Fast forward to June and the National Institutes of Health (NIH) commenced NCI-MATCH, the world’s largest ever precision oncology trial. It is clear that precision medicine is no longer futuristic or conceptual—the movement is happening now, with healthcare stakeholders steadfast in the conclusion that medicine will need to focus on finding the right therapies for the right patients at the right time. But developing these precision therapies will require a new set of tools and a new way of thinking. Luckily, advances in technology have equipped us with research techniques we never before thought possible, as well as technical capabilities to manage and manipulate unprecedented volumes of data. Prepared with these new means, we are on the brink of great discovery. One critical component, however, is still lagging behind: The organization, procurement, and dissemination of high-quality, well-annotated human biospecimens on which to conduct the critical biomedical research to find tomorrow’s cures.

Read more

In the News

A New Role for Hospitals and Labs

June 30, 2015 - Advance for Laboratory - To accomplish all of this research, the precision medicine movement has, in turn, created an increased demand for human biospecimens - and, in particular, well-annotated biospecimens (i.e., biospecimens coupled with detailed specimen- and patient-level data). Well-annotated human biospecimens are biological "snapshots" of a patient during a specific moment in time and the cornerstone of effective translational research. Amazingly, at a time when we are studying disease at the genomic level, researchers still rely upon long-standing, frozen biospecimen inventories that often have very little patient data associated with them and therefore do not meet research needs. As personalized medicine develops and the role of the biospecimen becomes even more prominent, an emerging role for hospitals and labs becomes starkly apparent. The way we currently collect, store and annotate human biospecimens will have to change - a new model is needed.

Read more

In the News

EHR Big Data, Lab Specimens Enable Precision Medicine Research

June 30, 2015 - Health IT Analytics - When it comes to medical research and the rapidly expanding reach of precision medicine, physical specimens play a critical role in developing the big data later used for large-scale analytics that generate insights and produce results. Hospitals and clinics collect enormous amounts of blood, tissue, and other materials on a daily basis to use for diagnostic testing, but the remains of these samples don’t always make it into the hands of researchers and academics looking to further clinical trials and other projects. At Aurora Health Care, a fifteen-hospital chain based in Wisconsin, the Biorepository and Specimen Resource Center (BSRC) based at Aurora St. Luke’s Medical Center is helping to solve this problem by ensuring that patient specimens can be appropriately and securely used by researchers within the health system and across the country.

Read more

In the News

Technology Connects Lab-Discarded Specimens with Researchers; Provides Labs New Revenue

June 17, 2015 - G2 Intelligence - Technology is making use of hospital and laboratory specimens that would otherwise be discarded by connecting those specimen sources with biomedical researchers. iSpecimen (Lexington, Mass.), founded in 2009, links researchers with specimens from participating health care organizations and announced a new technology this month that uses its cloud-based platform, de-identified electronic medical record data and big data analytics to customize and increase the speed of that process.

Read more

Press Releases

iSpecimen® Expands Management Team with Doug Williams as Chief Technology Officer

Lexington, Mass – June 1, 2015 – iSpecimen, a trusted source of customized human biosp ecimen collections, is pleased to announce the appointment of Doug Williams to the position of Chief Technology Officer (CTO). Williams will be responsible for leading the team that builds out iSpecimen’s state-of-the-art, cloud-based platform that matches biomedical researchers with high quality, richly-annotated human biospecimens that would otherwise be discarded by hospitals and labs after clinical testing is complete.

Read more

In the News

iSpecimen Technology Consolidates the Procurement Process for Human Biospecimens

May 17, 2015 - Advance for Laboratory - iSpecimen, a source of customized human biospecimen collections, has released its latest technology that connects biomedical researchers to high quality, annotated human biospecimens that would otherwise be discarded by hospitals and labs after clinical testing is complete. Through this model, researchers gain access to the specimens they need from the patients they want and healthcare providers gain a new opportunity to contribute to biomedical research while improving their bottom line.

Read more

Press Releases

iSpecimen® Technology Consolidates the Procurement Process for Human Biospecimens

Lexington, Mass – May 5, 2015 – iSpecimen, a trusted source of customized human biospecimen collections, today released its latest technology that connects biomedical researchers to high quality, annotated human biospecimens that would otherwise be discarded by hospitals and labs after clinical testing is complete. Through this model, researchers gain access to the specimens they need from the patients they want and healthcare providers gain a new opportunity to contribute to biomedical research while improving their bottom line.

Read more

Press Releases

iSpecimen Closes $8 Million in Financing

June 3, 2014 -- iSpecimen announced today it has secured $8 million in capital in its Series B Financing. New investor OneBlood™, Inc., through a wholly owned subsidiary, in conjunction with existing investors, will help grow iSpecimen’s healthcare partner network and scale operations to meet the ever increasing needs of its research customers for annotated human biospecimens.

Read more

Press Releases

iSpecimen announces the formation of its partner program for hospitals, commercial labs, specialty clinics and practice groups

May 2014 -- iSpecimen announced the formation of the iSpecimen Partner Program. This turnkey program includes technology to automate the selection, annotation and management of laboratory discards; access to iSpecimen’s sales and marketing channel; compliance support; and laboratory SOPs to facilitate the disposition of clinical waste into medical research.

Read more

Press Releases

iSpecimen Deploys its Specimen Management Technology Across its Network of Clinical Laboratories

Jan. 2014 -- iSpecimen announced the deployment of the industry’s first federated specimen management system that greatly accelerates the pace at which scientists can obtain biospecimens for their research. The company’s Specimen Management System enables iSpecimen to deliver human biospecimens to the academic, diagnostic and pharmaceutical research community faster and with more consistent quality than traditional manual selection processes. The company also announced the availability of clinical specimen remnants – such as plasma, serum and urine – using this pioneering technology.

Read more

Press Releases

iSpecimen Announces the Closing of a Seed Financing Round

Jul. 2012-- iSpecimen announced today the closing of a $2.0M seed financing round. Led by private investors, the investment will be used to complete the development of the first version of its proprietary technology, which watches the flow of specimens in its network of clinical laboratories to match them to medical researchers’ customized specimen requests.

Read more

Press Releases

iSpecimen Selected as a Finalist in the MassChallenge Accelerator & Startup Competition

May 2012 -- iSpecimen has been selected as a finalist in the MassChallenge, an accelerator and startup competition. Finalists in the competition are provided mentorship, networking opportunities, free office space, and the chance to compete for $1M in funding at the end of the three month program.

Read more

In the News

New MOOD That Could Transform Healthcare: Massive Open Online Data

At innovative companies such as iSpecimen, previously-used human clinical specimens are prospectively supplied “on demand” to the research, therapeutic and diagnostic industries. Such specimens include plasma, serum, whole blood, urine, CSF and tissue that are provided according to the needs of the customers’ study requirements. iSpecimen tracks millions of specimens, and the associated patient data that flows through its clinical partner network—which includes hospitals, commercial laboratories, specialty clinics and academic institutions. From them, the company is able to obtain remnant samples and de-identified patient data to help advance medical research, with partnership agreements that benefit both parties. Though the specimens are anonymized, demographic and clinical indicators such as specimen type, age, gender, ICD9 codes and test results are provided with the specimens for research optimization. According to Christopher Ianelli, M.D., Ph.D., founder and CEO of iSpecimen, “In today’s world of personalized medicine, researchers struggle to procure biospecimens from trusted sources. Often, they have to cobble together specimens and data from dozens of sources just to find enough specimens for their studies. The combination of iSpecimen’s pioneering Specimen Management System along with our robust network of clinical laboratory partners provides researchers with a steady supply of high-quality, annotated biospecimens.” Since a recent National Institutes of Health (NIH) article highlighted the increased interest in translational research and the concomitant need for researchers to be able to collect relevant and useful samples for their research, it would seem that iSpecimen is definitely onto something big.
- The New MOOD That Could Transform Healthcare: Massive Open Online Data
By Sue Montgomery, RN, BSN on Thursday 1st of May 2014
nuviun.com/blog

Read more

In the News

97 New England startups are MassChallenge Finalists

Mass HighTech News

Read more

In the News

Meet the 2012 MassChallenge Finalists – All 125 of Them

BostInno

Read more

In the News

iSpecimen Named MassChallenge Finalist

Boston Business Journal

Read more

In the News

Harvard Business School Holds First Alumni New Venture Contest

Read more

The iSpecimen Marketplace

Search for Samples and Data Today

Create a login in seconds, for free, with no obligation. Gain immediate access to our real-time sample inventory today.

Already signed up?  Login to search our updated inventory.

Sign Up to Search the Marketplace